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Abstract: Human enteroviruses are the major cause of aseptic meningitis and are resistant to all known antibiotics and 
chemotherapeutic agents. Methanolic extracts of Eucalyptus camaldulensis and Eucalyptus torelliana were tested on 
human enteroviruses: Poliovirus type I, Coxsackievirus B and Echovirus 6. The virucidal tests showed that the crude 
extracts were active on the test viruses: poliovirus type 1, coxsackievirus B and echovirus 6 giving a neutralization index 
of one log and above. The cytotoxicity assay of the crude extracts to L20B (a genetically engineered mouse cell line) and 
human rhabdomyo sarcoma (RD) cells showed that the extract of E. torelliana was more toxic than the extract of E. 
camaldulensis. The antiviral study showed that the extract of E. torelliana was more active than that of E. camaldulensis. 
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INTRODUCTION 
 
The present striking contrast between bacteria and viruses 
in the availability of effective antimicrobial therapy arises 
from a number of special difficulties. In antibacterial 
therapy, most successful anti-infective agents inhibit 
essential steps in the metabolic processes required by the 
pathogen but absent in the host. Due to the metabolic 
properties of viruses, they are difficult to control and there 
are still relatively few drugs for treatment of viral diseases 
(Müller et al., 2007). However, increased understanding 
of the molecular events of virus infections has meant the 
search for antiviral drugs against specific targets can be 
conducted on a more rational basis. 
 
Over the years, compounds isolated from plants have 
been shown to possess antiviral properties. Ishitsuka et 
al., (1982) reported that a flavone isolated from 
Agastache folium was active against rhinoviruses (20 
types), coxsackievirus (A21 and B21) and poliovirus 
(Sabin). This natural flavonoid has a good antiviral 
activity in cell culture against most picornaviruses 
without showing toxicity to growing cells. Carlucci et al., 
(1997) reported that a sulphated galactan isolated from 
extracts of Cryptoleura ramose, a sea weed, was a 
selective inhibitor of HSV-1 and HSV-2 replication in 
vero cells. The ethanolic extracts of Aframomum 
melegueta had been shown to inhibit measles and yellow 
fever viruses by standard laboratory tests (Ojo et al., 
2009). 
 
Eucalyptus belongs to the family myrtaceae. It is a large 
genus of aromatic trees of over 600 species indigenous to 
Australia and Tasmania and the neighbouring island but 
now grows in all tropical and subtropical areas. 
Eucalyptus globulus is one of the most important species 
and its essential oil is mostly used for medicinal purposes. 
The leaves have medicinal purposes. A decoction of the 
leaves is prescribed for bronchial and pulmonary bacterial 
and viral infections. Eucalyptus is virucidal as reported by 
Takasaki et al., (1990). Twelve euglobals broken down 
into twenty six related compounds were isolated from 
euglobulus and eight of them showed strong inhibition in 
Epstein Barr viral activation in the lab. The bark extract of 
E. camaldulensis has been previously reported to show 
inhibition zones of comparable magnitude with those of 
the standard antimicrobial agents (Nagpal et al., 2010). 
Human enteroviruses are the major cause of aseptic 
meningitis. They include polioviruses, coxsackieviruses, 
echoviruses and enteroviruses. Enteroviruses are resistant 
to all known antibiotics and chemotherapeutic agents. The 
present study is designed to investigate the antiviral 
activities of the leaves of E. camaldulensis and E. 
torelliana against three of the enteroviruses namely: 
poliovirus type I, echovirus 6 and coxsackievirus B.  
 
MATERIALS AND METHODS 
 
Plant Material 
Branches of the stem of E. camaldulensis and E. 
torelliana were collected from the Department of Forestry 
of the University of Ibadan and authenticated at the 
Herbarium of the Department of Botany and 
Microbiology, University of Ibadan. 
 
Extraction 
Four hundred grams each of the dried powdered leaves of 
E. camaldulensis and E. torelliana was extracted 
exhaustively with methanol. The extracts were 
concentrated in vacuo before being air dried to constant 
weight. The leaves of E. camaldulensis yielded a *Corresponding author: e-mail: baadeniyi@yahoo.co.uk 
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brownish-black extract (76.05g) while E. torelliana 
yielded a shiny black extract (76.26g). 
 
Cells and viruses 
L20B (a genetically engineered mouse cell line) and 
human rhabdomyo sarcoma (RD) cells were cultured at 
37oC in Eagle’s minimal essential medium (SIGMA) 
supplemented with 10% fetal calf serum. For cell 
maintenance, the serum concentration was lowered to 2%. 
 
Poliovirus type I, echovirus 6 and coxsackievirus group B 
obtained from the Department of Virology, University 
College Hospital Ibadan were used in this study. 
Poliovirus was propagated in L20B cells while echovirus 
6 and coxsackievirus B were propagated in RD cells. 
 
Determination of cellular toxicity of extracts on L20B 
and RD cells 
The highest non-toxic concentration of ach of the extracts 
on L20B and RD cells was determined by inoculating 
different concentrations of the extract into cells while 
comparing the results to the cell control. Confluent L20B 
and RD cell monolayers grown in 96 well tissue culture 
plates (Falcon) were washed and exposed to two fold 
serial dilutions of the extracts from 50mg/ml to 
0.36mg/ml in 2% minimal essential medium for 7 days at 
37oC. Cells with maintenance medium alone served as 
negative control. Cell morphology (e.g. rounding up, 
shrinking, detachment) and viability relative to the 
negative control were examined by light microscopy to 
determine the highest non-toxic concentration of the 
extract. 
 
Antiviral assay 
Antiviral properties of the plant extracts were determined 
by cytopathic effect inhibition assay and virus yield 
reduction assay. 
 
The highest non-toxic concentration of each extract was 
incubated with titre of the poliovirus (104 TCID50) in 
equal proportion (1:1) at 37oC for I hour. High titres of 
echovirus 6 (104 TCID50) and coxsackievirus B (104 
TCID50) were treated the same as described above. 
Meanwhile, 90µl of Eagle’s minimal essential medium 
was dispensed into a 96 well plate. A 10µl of the extract-
virus mixture was added into the top wells and a serial ten 
fold dilution was made starting from 10-1 to 10-7 
(quadruplicate for each dilution). The last row was used 
as a negative control without extract-virus mixture. About 
100µl of L20B or RD cells (as applicable) suspended in 
10% Eagle’s minimal essential medium was distributed 
into the cells and incubated at 37oC for seven days. The 
viability of the infected and non-infected cells was 
evaluated by determining the virus titre. The difference in 
log10 virus titre between the treated viruses and non-
treated viruses indicated as the neutralization index (NI) 
was determined. A difference of 1 log or more indicated 
that the extract was active.  
Table 1: Highest Non-toxic Concentration of the Crude Extracts on L20B and RD Cells 
 
Plant Extract Cell line Highest non-toxic concentration mg/ml 
L20B 12.5 E. camaldulensis 
RD 6.25 
L20B 6.25 E. torelliana 
RD 3.13 
 
Table 2: Antiviral Activity of the Extracts on Poliovirus I 
 
Plant Extract Titre (Non-treated) Titre (treated) Difference In Titre (NI) Inference 
E. camaldulensis 5.5 log 4.25 log 1.2 log Active 
E. torelliana 5.5 log 4.0 log 1.5 log Active 
 
Table 3: Antiviral Activity of the Extracts on Coxsackievirus B 
 
Plant Extract Titre (Non-treated) Titre (treated) Difference in Titre (NI) Inference 
E.camaldulensis 4.75 log 3.75 log 1.0 log Active 
E. torrelliana 4.75 log 3.5 log 1.25 log Active 
 
Table 4: Antiviral Activity of the Extracts on Echovirus 6 
 
Plant Extract Titre (Non-treated) Titre (treated) Difference in Titre (NI) Inference 
E. camaldulensis 6.25 log 4.25 log 2.0 log Active 
E. torelliana 6.25 log 4.0 log 2.25 log Active 
Bolanle Alake Adeniyi et al 
Pak. J. Pharm. Sci., Vol.28 No.5, September 2015, pp.1773-1776 1775
RESULTS 
 
The results of the toxicity assay of the crude extracts on 
L20B and RD cells are shown in table 1.The results 
showed that the crude extract of E. torelliana had the 
highest non-toxic concentration of 3.13 mg/ml on RD 
cells and 6.25 mg/ml on L20B cells. E. camaldulensis had 
the highest non-toxic concentration of 6.25 mg/ml on RD 
cells and 12.5 mg/ml on L20B cells. 
 
The results of the antiviral assay are presented on tables 2, 
3 and 4. The difference in titre between the treated 
viruses and non-treated viruses revealed a difference of 1 
log or more indicating that both extracts were active on 
the test viruses. E. torelliana was observed to have 
antiviral activity on all test viruses than E. camaldulensis. 
 
DISCUSSION 
 
The results of the cellular toxicity assay of extracts of E. 
camaldulensis and E. torelliana on L20BB and RD cells 
showed that E. camaldulensis had a higher non-toxic 
concentration than E. torelliana on both cells. This is an 
indicator that its phytochemical constituents are less toxic 
than those of E. torelliana. It is however necessary to 
carry out cytotoxic assay in vivo to establish its safety as a 
therapeutic agent. 
 
In this study, the antiviral activities of the extracts of E. 
camaldulensis and E. torelliana were assessed and gave 
interesting results. The results showed that the extracts 
had activity on the test viruses. The results showed that 
the highest activity was on echovirus 6, followed by 
poliovirus type I while the least activity was on 
coxsackievirus B. The results clearly indicated that E. 
torelliana had higher activity on all test viruses. 
 
Previous phytochemical screening of E. camaldulensis 
revealed the presence of tannins, saponins and 
cardenolides. E. torelliana was found to contain tannins, 
saponins, cardenolides and in addition anthraquinones. 
Phytochemicals are known to activate the lymphocytes of 
infected individuals and also prevent forming of 
resistance in viruses and viral replication (Chiang, 2003).  
 
Plants contain a wide variety of diverse phytochemicals, 
such as alkaloids, tannins, saponins, flavonoids, 
terpenoids, lignans, coumarins, and many other 
components; the modes of action of which are multi-
facetted Perera and Efferth (2012). The antiviral activity 
of the extracts of E. camaldulensis and E. torelliana could 
be traceable to the presence of hydrolysable tannins-
ellagitannins. Ellagitannins have been reported to possess 
antiviral and antitumor properties (Kenner and Requena, 
1996). In this study, the higher activity of E. torelliana 
could be traceable to the presence of anthraquinones 
which were absent in E. camaldulensis. Hu-Chang 
obtained from Polygonus cupsidatum has been found to 
contain a number of anthraquinones such as emodin, 
physcion, chrysophanol and resveratrol. In vitro studies 
showed that the herb extract could inhibit poliovirus, 
coxsackieviruses A and B, echoviruses, influenzavirus, 
herpes simplex virus, adenovirus and encephalitis B virus. 
Eucalyptus is known to possess flavonoids (Kulheim et 
al., 2011). Peng et al., (1995) reported the antiviral 
activity of Astragalus a qi tonic herb which has been 
researched for coxsackie induced cardiomyopathy. The 
active ingredients in astragalus include flavonoids and 
saponins. Through this finding, the presence of saponins 
in E. camaldulensis and E. torelliana may have 
contributed to their antiviral activity.  
 
According to literature, the non-enveloped nature of 
enteroviruses makes them resistant to most antimicrobial 
agents which usually act directly on the envelope. Non-
enveloped viruses are known to display higher intrinsic 
resistance based on their structure McDonnell and Burke 
(2011). 
 
Although this study was not designed to identify the 
mechanisms of action of the compounds, pre-clinical 
evaluation of the extracts of E, camaldulensis and E. 
torelliana for their activity in vitro with respect to both 
antiviral efficacy and cellular toxicity which was carried 
out showed that the extracts have promising activity in 
development of effective antiviral drugs for the treatment 
of enteroviral infections. Further investigations making 
use of the pure extracts is however necessary to establish 
the prophylactic and therapeutic basis of E. camaldulensis 
and E. torelliana. 
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